In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017–2021

In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017–2021

ABSTRACT: Objectives: To report the in vitro susceptibility of Enterobacterales (n = 3905) and Pseudomonas aeruginosa (n = 1,109) isolates, collected from patients in sub-Saharan Africa (four countries) in 2017–2021, to a panel of 10 antimicrobial agents with a focus on ceftazidime-avibactam activi...

Full description

Bibliographic Details
Main Authors: Mark G. Wise, James A. Karlowsky, Meredith A. Hackel, Mohamed Amine Harti, Bontle M.E. Ntshole, Eva Njeri Njagua, Rita Oladele, Catherine Samuel, Shameema Khan, Jeannette Wadula, Warren Lowman, Busisani W. Lembede, Daniel F. Sahm
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Enterobacterales
Pseudomonas aeruginosa
Ceftazidime-avibactam
Surveillance
Antimicrobial susceptibility
sub-Saharan Africa
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716523001558

Internet

http://www.sciencedirect.com/science/article/pii/S2213716523001558

Similar Items